SemEval-2013 Task 9 : Extraction of Drug-Drug Interactions from Biomedical Texts (DDIExtraction 2013)
暂无分享,去创建一个
Paloma Martínez | Isabel Segura-Bedmar | María Herrero-Zazo | Isabel Segura-Bedmar | Paloma Martínez | María Herrero-Zazo
[1] Erik F. Tjong Kim Sang,et al. Introduction to the CoNLL-2003 Shared Task: Language-Independent Named Entity Recognition , 2003, CoNLL.
[2] Mariana L. Neves,et al. WBI-DDI: Drug-Drug Interaction Extraction using Majority Voting , 2013, *SEMEVAL.
[3] Dale W. Quest,et al. Stockley’s drug interactions. 8th edition; Stockley’s drug interactions 2008 pocket companion , 2008 .
[4] César de Pablo-Sánchez,et al. Using a shallow linguistic kernel for drug-drug interaction extraction , 2011, J. Biomed. Informatics.
[5] Rafael Muñoz,et al. UMCC_DLSI: Semantic and Lexical features for detection and classification Drugs in biomedical texts , 2013, SemEval@NAACL-HLT.
[6] Mariana L. Neves,et al. Extraction of biomedical events using case-based reasoning , 2009, BioNLP@HLT-NAACL.
[7] K. Bretonnel Cohen,et al. UColorado_SOM: Extraction of Drug-Drug Interactions from Biomedical Text using Knowledge-rich and Knowledge-poor Features , 2013, SemEval@NAACL-HLT.
[8] Jari Björne,et al. Comparative analysis of five protein-protein interaction corpora , 2008, BMC Bioinformatics.
[9] Alberto Díaz,et al. NIL_UCM: Extracting Drug-Drug interactions from text through combination of sequence and tree kernels , 2013, SemEval@NAACL-HLT.
[10] Alberto Lavelli,et al. FBK-irst : A Multi-Phase Kernel Based Approach for Drug-Drug Interaction Detection and Classification that Exploits Linguistic Information , 2013, *SEMEVAL.
[11] Jeffrey Aronson. Communicating information about drug interactions , 2007 .
[12] Jari Björne,et al. UTurku: Drug Named Entity Recognition and Drug-Drug Interaction Extraction Using SVM Classification and Domain Knowledge , 2013, *SEMEVAL.
[13] Majid Rastegar-Mojarad,et al. UWM-TRIADS: Classifying Drug-Drug Interactions with Two-Stage SVM and Post-Processing , 2013, SemEval@NAACL-HLT.
[14] Francisco M. Couto,et al. LASIGE: using Conditional Random Fields and ChEBI ontology , 2013, SemEval@NAACL-HLT.
[15] Isabel Segura-Bedmar,et al. The 1st DDIExtraction-2011 challenge task: Extraction of Drug-Drug Interactions from biomedical texts , 2011 .
[16] Alberto Lavelli,et al. Exploiting the Scope of Negations and Heterogeneous Features for Relation Extraction: A Case Study for Drug-Drug Interaction Extraction , 2013, HLT-NAACL.
[17] Beth Sundheim,et al. MUC-5 Evaluation Metrics , 1993, MUC.
[18] Md. Faisal Mahbub Chowdhury. Improving the Effectiveness of Information Extraction from Biomedical Text , 2013 .
[19] Jari Björne,et al. EXTRACTING CONTEXTUALIZED COMPLEX BIOLOGICAL EVENTS WITH RICH GRAPH‐BASED FEATURE SETS , 2011, Comput. Intell..
[20] Dan Boring,et al. The Development and Adoption of Nonproprietary, Established, and Proprietary Names for Pharmaceuticals , 1997 .
[21] Daniel Sánchez-Cisneros,et al. UEM-UC3M: An Ontology-based named entity recognition system for biomedical texts. , 2013, *SEMEVAL.
[22] Ulf Leser,et al. WBI-NER: The impact of domain-specific features on the performance of identifying and classifying mentions of drugs , 2013, *SEMEVAL.
[23] Ulf Leser,et al. ChemSpot: a hybrid system for chemical named entity recognition , 2012, Bioinform..
[24] Daniel Sánchez-Cisneros. UC3M: A kernel-based approach to identify and classify DDIs in bio-medical texts , 2013, SemEval@NAACL-HLT.
[25] Claudio Giuliano,et al. Exploiting Shallow Linguistic Information for Relation Extraction from Biomedical Literature , 2006, EACL.
[26] Alberto Lavelli,et al. Impact of Less Skewed Distributions on Efficiency and Effectiveness of Biomedical Relation Extraction , 2012, COLING.
[27] David S. Wishart,et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration , 2005, Nucleic Acids Res..
[28] Juliane Fluck,et al. SCAI: Extracting drug-drug interactions using a rich feature vector , 2013, SemEval@NAACL-HLT.